Wells Fargo’s AstraZeneca AZN Stock Holding History

Wells Fargo’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.3M	Buy	+98,000	New	+$18.9M	﹤0.01%	1537
2025 Q2	–	Sell	-25,000	Closed	-$3.67M	–	7142
2025 Q1	$3.67M	Buy	+25,000	New	+$3.62M	﹤0.01%	2654
2022 Q1	–	Sell	-700	Closed	-$82K	–	7039
2021 Q4	$82K	Buy	+700	New	+$82.4K	﹤0.01%	5738
2021 Q2	–	Sell	-141,650	Closed	-$14.1M	–	6892
2021 Q1	$14.1M	Buy	141,650 +41,900	+42%	+$4.21M	﹤0.01%	1932
2020 Q4	$18K	Buy	99,750 +74,750	+299%	+$7.92M	﹤0.01%	5875
2020 Q3	$20K	Sell	25,000 -25,000	-50%	-$2.78M	﹤0.01%	5750
2020 Q2	$28K	Buy	+50,000	New	+$5.16M	﹤0.01%	5624
2019 Q1	–	Sell	-24,950	Closed	-$49K	–	6040
2018 Q4	$49K	Hold	24,950	–	–	﹤0.01%	5522
2018 Q3	$143K	Hold	24,950	–	–	﹤0.01%	5188
2018 Q2	$50K	Buy	+24,950	New	+$1.79M	﹤0.01%	5590
2017 Q3	–	Sell	-700	Closed	-$1K	–	6302
2017 Q2	$1K	Buy	+700	New	+$45.7K	﹤0.01%	6098
2017 Q1	–	Sell	-50,400	Closed	-$11K	–	6297
2016 Q4	$11K	Buy	+50,400	New	+$2.86M	﹤0.01%	5766
2015 Q1	–	Sell	-121,300	Closed	-$46K	–	6158
2014 Q4	$46K	Hold	121,300	–	–	﹤0.01%	5032
2014 Q3	$305K	Buy	121,300 +21,300	+21%	+$1.56M	﹤0.01%	4152
2014 Q2	$7.43M	Buy	+100,000	New	+$7.23M	﹤0.01%	2028

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Wells Fargo's AZN Position: Q1 2026 in Review

Wells Fargo reduced its AstraZeneca (AZN) stake by 0.44% in Q1 2026, selling an estimated $1.31M and leaving 1,544,632 shares worth $305M. The position accounts for 0.06% of the portfolio, ranked #280.

Wells Fargo first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Wells Fargo held 1,544,632 shares of AstraZeneca worth $305M as of Q1 2026.
Wells Fargo sold 6,794 AstraZeneca shares in Q1 2026, an estimated $1.31M.
AstraZeneca made up 0.06% of Wells Fargo's portfolio in Q1 2026, its #280 holding.
Wells Fargo first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.